Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
World melanoma expert exposes sailor’s skin cancer risk
By Richard Schoonraad | Cancer, Cancer, Immunotherapy, Melanoma, Melanoma Discovery, Melonoma, News & Events, ResearchPerth based cancer researcher Professor Jonas Nilsson regularly sees in his laboratory just how damaging sun exposure is to our skin as he investigates ways to treat melanoma, the most…
New biomarker predicts liver cancer recurrence and immunotherapy response
By Richard Schoonraad | Cancer, Cancer, Cancer and Cell Biology, Disease Area, Immunotherapy, Liver Cancer, Liver Cancer, Liver Disease, Liver Disease, News & Events, Research, Tumours, xOncofetal EcosystemAnalysis of the environment that surrounds liver cancer tumours has revealed that patients with a high concentration of a certain cell type have early return of aggressive cancer but do…
WA researchers excel in nationally competitive grants
By Richard Schoonraad | Breast Cancer, Breast Cancer, Cancer, Cancer, Cancer Epigenetics, Cardiovascular Disease, Cardiovascular Disease, Epigenetics and Genomics Laboratory, Funding, Genome Biology and Genetic Diseases, Media Releases, Mitochondrial disease, Mitochondrial Disease, Mitochondrial Medicine and Biology, News & Events, Research, TranslationEight (8) Federal government grants awarded to the Harry Perkins Institute of Medical Research Two of Australia’s most significant research grants, given only to the nation’s highest performing researchers, have…
$3.5 million research collaborative brings cell therapy for solid cancers to WA
By Richard Schoonraad | Cancer, Cancer, Funding, Melanoma, Melanoma Discovery, Melonoma, News & Events, Personalised Medicine, ResearchResearchers from the Western Australia Melanoma Initiative (WAMI), a cancer research collaborative, will implement a specialised immune cell therapy for cancer patients in WA, thanks to a $2.5 million grant…
New discovery for treatment of primary liver cancer shows promise
By Richard Schoonraad | Cancer, Cancer, Cancer Epigenetics, Disease Area, Epigenetics and Genomics Laboratory, Lab, Liver, Liver Cancer, Liver Cancer, Liver Disease, Mitochondrial Medicine and Biology, News & Events, ResearchA study using preclinical models has discovered a drug combination with the potential to treat one of the most fatal and globally widespread cancers, a type of primary liver cancer…
Scientists find way to wipe a cell’s memory to better reprogram it as a stem cell
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cells, Epigenetics and Genomics Laboratory, News & EventsIn a groundbreaking study published today in Nature, Australian scientists have resolved a long-standing problem in regenerative medicine. Led by Professor Ryan Lister from the Harry Perkins Institute of Medical…
Researchers find link to anti-ageing element
By Richard Schoonraad | Cancer, News & Events, Research, xOncofetal EcosystemResearchers discover that increasing a naturally occurring chemical slows ageing process Ageing is inevitable as systemic changes occur in our bodies, but the question that puzzled researchers at the Harry…